About: James Chih-Hsin Yang

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: James Chih-Hsin Yang Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	researcher (en) 연구원 (ko) ricercatore (it) গবেষক (bn) 研究者 (ja) investigador (es) chercheur (fr) wetenschapper (nl) дослідник (uk) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) hulumtues (sq) researcher (en-ca) researcher (en-gb) researcher (en-us) investigador (ca) investigador (gl) investigador (ast) investigador (pt)
exact match	wds:Q37840097-608476E7-FFE7-4A51-9465-E64A09C6E739
exact match	https://scigraph.springernature.com/person.011747567444.50
rdfs:label	James Chih-Hsin Yang (en) James Chih-Hsin Yang (de) James Chih-Hsin Yang (es) James Chih-Hsin Yang (fr) James Chih-Hsin Yang (it) James Chih-Hsin Yang (nl) James Chih-Hsin Yang (sl) James Chih-Hsin Yang (ast)
skos:prefLabel	James Chih-Hsin Yang (en) James Chih-Hsin Yang (de) James Chih-Hsin Yang (es) James Chih-Hsin Yang (fr) James Chih-Hsin Yang (it) James Chih-Hsin Yang (nl) James Chih-Hsin Yang (sl) James Chih-Hsin Yang (ast)
name	James Chih-Hsin Yang (en) James Chih-Hsin Yang (de) James Chih-Hsin Yang (es) James Chih-Hsin Yang (fr) James Chih-Hsin Yang (it) James Chih-Hsin Yang (nl) James Chih-Hsin Yang (sl) James Chih-Hsin Yang (ast)
Scopus author ID	wds:Q37840097-1D531F01-EA0F-403A-AB95-209CD8DD050F
Scopus author ID	36718416100
given name	wds:Q37840097-490144A4-7A49-4416-A39A-EBE1C4C92428
given name	James
instance of	wds:Q37840097-2A4CEF7F-067F-4531-8B96-B9311A40AF9B
instance of	Homo sapiens
skos:altLabel	Chih-Hsin Yang (en)
occupation	wds:Q37840097-A23B2E3D-08D5-46AF-8766-B2AE11D439A3
employer	wds:Q37840097-08E8B9E4-7518-4D78-82E2-AFE17675A57A wds:Q37840097-420E15A1-B64C-4035-AD40-F6141F601E3D
sex or gender	wds:Q37840097-7ABEF855-205F-47AF-A0D7-36B8E23A1996
ISNI	wds:Q37840097-862E919E-DA31-4E54-811B-42F30C16C14E
VIAF ID	wds:Q37840097-FD3F4752-4D20-4770-B996-BCD7609051A0
Library of Congress authority ID	wds:Q37840097-A507DFCD-57B9-47AC-BD8F-4BF7CA7EA44A
date of birth	wds:Q37840097-7635D946-59A6-48D4-ADAD-D2F44D9E5B09
date of death	wds:Q37840097-f721060d-860d-4315-9531-aace9f69a5d4
educated at	wds:Q37840097-897DCB98-EC8A-4F64-A0B8-B3B5B8C6A340 wds:Q37840097-DBE15E66-2DE7-4D08-8928-8352AD860A62
WorldCat Identities ID (superseded)	wds:Q37840097-497565E8-41DE-47EA-8B92-7789445A3B42
National Library of Spain ID	wds:Q37840097-942DCD38-9759-490A-94F7-DE5B1965FF38
VIAF ID	http://viaf.org/viaf/1464910
Library of Congress authority ID	http://id.loc.gov/authorities/names/n85311063
National Library of Spain ID	http://datos.bne.es/resource/XX5375238
occupation	researcher
employer	National Taiwan University National Taiwan University Hospital
sex or gender	male
ISNI	0000000063567734
VIAF ID	1464910
Library of Congress authority ID	n85311063
date of birth	1936-01-01 00:00:00Z (xsd:dateTime)
date of death	2018-05-30 00:00:00Z (xsd:dateTime)
educated at	National Taiwan University
WorldCat Identities ID (superseded)	lccn-n85311063
National Library of Spain ID	XX5375238
ORCID iD	wds:Q37840097-27EDD465-03D3-4661-8377-D2DF066DF9F0
Dimensions author ID	wds:Q37840097-EAAC0260-168D-4CB6-AA44-A952E97B5FFD
ORCID iD	https://orcid.org/0000-0002-5586-5138
ORCID iD	0000-0002-5586-5138
Dimensions author ID	011747567444.50
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37840097
is author of	Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies. Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS) Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1. Diarrhea associated with afatinib: an oral ErbB family blocker Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations. EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6. Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software